A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986278 in Healthy Chinese Participants
Clinical trial NCT05805904 · COMPLETED
Trial details
- NCT number
- NCT05805904
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2023-05-23
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.